The potential vaccine has been developed by Novavax, a United States biopharmaceutical company. It's previously made novel vaccines for MERS [[Middle Eastern Respiratory Syndrome]], SARS [[Severe Acute Respiratory Syndrome]], and Ebola.
First clinical trial in Southern hemisphere of potential COVID-19 vaccine
A computer model showing the protein structure of a potential COVID-19, vaccine at Novavax labs in Gaithersburg, Maryland on March 20, 2020, Source: AFP via Getty Images
Around 10 experimental Coronavirus vaccines are already being tested on people around the globe. And now, the first clinical trial in the Southern hemisphere has begun at Alfred Hospital in Melbourne.
Share
